TAFAZZIN and Barth syndrome: The importance of the CL remodeling pathway is underscored by the life-threatening disease Barth syndrome (BTHS), in which patients bear mutations in TAFAZZIN, the transacylase responsible for adding polyunsaturated fatty acid chains to monolyso-CL (MLCL) (1, 2, 3).